Efficacy and safety of agomelatine (25mg) given orally once a day for 6 weeks in elderly patients with Major Depressive Disorder. A randomised, double-blind, placebo-controlled, parallel-group study with a 18-week extension period

Authors
Category Primary study
Journal[Data from European Medicines Agency]
Year 2004
This article has no abstract
Epistemonikos ID: 1a54c8308547d75006edab4ba00f51645486b798
First added on: Feb 23, 2019